AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11281438
Drug: Clarithromycin 500
RxNorm normalized name: clarithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 500 mg tid + Omeprazole 20 mg bd
Trial: 9426077
Drug: Mannitol inhalation
RxNorm normalized name: mannitol inhalation kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mannitol inhalation (267 mg and 400 mg)
Trial: 9309990
Drug: Mannitol inhalation
RxNorm normalized name: mannitol inhalation kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mannitol inhalation
Trial: 3941767
Drug: Primidone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primidone (50 to 1,000 mg/d)
Trial: 3941767
Drug: Primidone (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primidone (250 mg single oral dose)
Trial: 23887656
Drug: Aliskiren add-on
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren add-on therapy
Trial: 23887656
Drug: Benazepril add-on
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benazepril add-on therapy
Trial: 17551539
Drug: Nicotine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (2 mg via polacrilex gums)
Trial: 8881668
Drug: Higher-dose regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher-dose regimen based on minimal phototoxic dose (MPD)
Trial: 8881668
Drug: Lower dose
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower dose regimen based on skin type
Trial: 1909584
Drug: ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ranitidine 150 mg nocte
Trial: 25295737
Drug: Bevacizumab +
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab + taxane-based chemotherapy
Trial: 20880343
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro mix 50/50 (LM50/50)
Trial: 20880343
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine plus ≤3 mealtime lispro (G+L)
Trial: 18035140
Drug: Insulin (0.025
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin (0.025 U/kg/hr) on days 1 to 7 with 20% dextrose to maintain normoglycemia
Trial: 12753317
Drug: Raloxifene hydrochloride,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene hydrochloride, 60 mg/day
Trial: 11421376
Drug: Albendazole 20
RxNorm normalized name: albendazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole 20 mg/kg with cimetidine 10 mg/kg twice daily
Trial: 11421376
Drug: Albendazole 5
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Albendazole 5 mg/kg
Trial: 8872129
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg IK-HIR02 (IV)
Trial: 8872129
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg IK-HIR02 (IV)
Trial: 8872129
Drug: 0.3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/kg IK-HIR02 (IV)
Trial: 8872129
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg IK-HIR02 (SC)
Trial: 8872129
Drug: 0.25 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/kg IK-HIR02 (SC)
Trial: 8872129
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg IK-HIR02 (SC)
Trial: 8872129
Drug: 0.3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/kg IK-HIR02 (SC, b.i.d.)
Trial: 8872129
Drug: Hirudin (0.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hirudin (0.7 micrograms/ml) as anticoagulant
Trial: 1900575
Drug: Thyroxine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyroxine (100 micrograms) and Methimazole (10 mg)
Trial: 1900575
Drug: Placebo and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo and Methimazole (10 mg)
Trial: 6823860
Drug: Clonidine (centrally
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (centrally acting agent)
Trial: 29746446
Drug: Corner Pocket
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corner Pocket technique (20 mL local anesthetic injected primarily in the corner pocket)
Trial: 29746446
Drug: Neural Cluster
RxNorm normalized name: cluster fig extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neural Cluster technique (20 mL local anesthetic injected primarily inside the neural cluster)
Trial: 26143238
Drug: Core decompression
RxNorm normalized name: diclofenac
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Core decompression with concentrated bone marrow injection (Group A)
Trial: 26143238
Drug: Core decompression
RxNorm normalized name: diclofenac
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Core decompression without bone marrow injection (Group B)
Trial: 20452184
Drug: Probiotic capsules
RxNorm normalized name: Quad-Probiotic Capsules
DrugBank: Bifidobacterium longum (DB19248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic capsules containing Lactobacillus acidophilus, Lactobacillus bulgaricus, Bifidobacterium lactis, and Streptococcus thermophiles for 6 months
Trial: 20452184
Drug: Probiotic capsules
RxNorm normalized name: Quad-Probiotic Capsules
DrugBank: Bifidobacterium longum (DB19248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic capsules for patients with baseline ammonia levels > 50 mmol/L
Trial: 17000789
Drug: Dopamine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine (2 mcg x kg(‐1) x min(‐1))
Trial: 1614100
Drug: Topical diclofenac
RxNorm normalized name: diclofenac Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical diclofenac (Voltaren Ophtha)
Trial: 27793396
Drug: Alirocumab 75/150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alirocumab 75/150 mg every 2 weeks (Q2W)
Trial: 18699977
Drug: Proton Pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton Pump Inhibitor (PPI) therapy
Trial: 20464583
Drug: Frovatriptan (F)
DrugBank: Frovatriptan (DB00998)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Frovatriptan (F) 2.5 mg
Trial: 22644174
Drug: Comparators (Rizatriptan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparators (Rizatriptan (R) 10 mg, Zolmitriptan (Z) 2.5 mg, Almotriptan (A) 12.5 mg)
Trial: 10597985
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A supplementation (single high dose every 4 months)
Trial: 11144995
Drug: ARA (adenosine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARA (adenosine receptor agonist)
Trial: 11144995
Drug: Hypothetical antagonist
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hypothetical antagonist
Trial: 7602348
Drug: Intense therapy
RxNorm normalized name: AVOBENZONE 30 g in 1000 g / OCTINOXATE 75 g in 1000 g / PETROLATUM 402 g in 1000 g TOPICAL OINTMENT [Intense Therapy Lip Balm Asian Pear]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intense therapy (cyclophosphamide 1,000 mg/m2 and cisplatin 100 mg/m2 intravenously every 3 weeks for four courses)
Trial: 7602348
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (cyclophosphamide 500 mg/m2 and cisplatin 50 mg/m2 intravenously every 3 weeks for eight courses)
Trial: 7602348
Drug: Intense therapy
RxNorm normalized name: AVOBENZONE 30 g in 1000 g / OCTINOXATE 75 g in 1000 g / PETROLATUM 402 g in 1000 g TOPICAL OINTMENT [Intense Therapy Lip Balm Asian Pear]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intense therapy
Trial: 2186769
Drug: Warfarin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (1 mg daily minidose)
Trial: 28780236
Drug: Tenecteplase 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenecteplase 0.4 mg/kg (max 40 mg)
Trial: 28780236
Drug: Alteplase 0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alteplase 0.9 mg/kg (max 90 mg)
Trial: 19841760
Drug: G‐Bond (GC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐Bond (GC)
Trial: 17376791
Drug: Tenofovir 300
RxNorm normalized name: tenofovir 300 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenofovir 300 mg once daily
Trial: 10378549
Drug: Empiric anti-PCP
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empiric anti-PCP therapy
Trial: 3959798
Drug: Preoperative gamma-therapy
RxNorm normalized name: gamma-octalactone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative gamma-therapy at a dose of 19.5 Gy
Trial: 3959798
Drug: Preoperative gamma-therapy
RxNorm normalized name: gamma-octalactone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative gamma-therapy at a dose of 30 Gy
Trial: 3959798
Drug: Preoperative gamma-therapy
RxNorm normalized name: gamma-octalactone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative gamma-therapy at a dose of 40 Gy
Trial: 31734084
Drug: Esketamine nasal
RxNorm normalized name: esketamine Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esketamine nasal spray plus an oral antidepressant
Trial: 31734084
Drug: New oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New oral antidepressant
Trial: 28991048
Drug: Hydrocortisone 300
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone 300 mg group (100 mg initial bolus followed by continuous infusion of 300 mg daily for 5 days)
Trial: 28991048
Drug: Hydrocortisone 200
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone 200 mg group (50 mg intravenous bolus every 6 h during 7 days)
Trial: 28991048
Drug: Nonresponders (CST
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonresponders (CST response of 9 μg/dL or less)
Trial: 25223164
Drug: Chewing gauze
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chewing gauze soaked with 20 ml of 2% lidocaine
Trial: 10023125
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human nerve growth factor (rhNGF) administered at doses of 0.1 or 0.3 microg/kg subcutaneously 3 days a week for 6 months.
Trial: 10023125
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human nerve growth factor (rhNGF) administered at doses up to 1.0 microg/kg intravenously or subcutaneously for up to 12 doses in phase I studies.
Trial: 8678284
Drug: Piritramide (bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piritramide (bolus 1.5 mg)
Trial: 1987875
Drug: Bile acid
RxNorm normalized name: Bile acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bile acid therapy compliance
Trial: 6857584
Drug: Indomethacin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (50 mg four times daily)
Trial: 25601896
Drug: Intramuscular single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular single dose of 300,000 IU vitamin D3
Trial: 17953631
Drug: Antioxidant pool
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant pool (AP) supplementation for 2 months before and 6 months during NB‐UVB treatment
Trial: 12037659
Drug: 100 ml
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 ml tomato juice with 300 mg HCA
Trial: 12037659
Drug: 100 ml
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 ml tomato juice (placebo)
Trial: 12555375
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (nitrendipine associated with enalapril or hydrochlorothiazide)
Trial: 1800166
Drug: Topical 2-(2-Hydroxy-4-methylphenyl)
RxNorm normalized name: benzocaine 0.2 MG/MG [Topicale]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 2-(2-Hydroxy-4-methylphenyl) Aminothiazole Hydrochloride 0.1% (CBS 113A)
Trial: 6391903
Drug: Olive oil
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive oil (30 ml)
Trial: 6391903
Drug: Linseed oil
RxNorm normalized name: linseed oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linseed oil (30 ml)
Trial: 29526850
Drug: Transcranial Direct
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcranial Direct Current Stimulation therapy
Trial: 29526850
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (Transcranial Direct Current Stimulation + Positive psychotherapy)
Trial: 26953280
Drug: U‐300 insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: U‐300 insulin glargine
Trial: 26953280
Drug: U‐100 insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: U‐100 insulin glargine
Trial: 25070099
Drug: 7-day standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day standard triple therapy (pantoprazole, clarithromycin, amoxicillin for 7 days)
Trial: 25070099
Drug: 10-day sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day sequential therapy (pantoprazole and amoxicillin for 5 days, followed by pantoprazole, clarithromycin, and metronidazole for a further 5 days)
Trial: 25070099
Drug: 7-day concomitant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day concomitant therapy (pantoprazole, clarithromycin, amoxicillin, and metronidazole for 7 days)
Trial: 16029670
Drug: 4% hydroquinone/0.3%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% hydroquinone/0.3% retinol cream
Trial: 11735710
Drug: 0.05% tretinoin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% tretinoin emollient cream
Trial: 10439767
Drug: Phenylephrine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylephrine infusion (0.5 microgram.kg‐1.min‐1 i.v.)
Trial: 2121150
Drug: Moderate dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate dose of alcohol (30 g in red port and wine) consumed during a standard dinner
Trial: 18782641
Drug: Exenatide twice
RxNorm normalized name: Exenatide
DrugBank: Exenatide (DB01276)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exenatide twice daily
Trial: 26545669
Drug: Ganoderma lucidum
RxNorm normalized name: GANODERMA LUCIDUM STEM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganoderma lucidum (6 g per day for 6 weeks)
Trial: 26545669
Drug: Ceratonia siliqua
RxNorm normalized name: CERATONIA SILIQUA WHOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceratonia siliqua (6 g per day for 6 weeks)
Trial: 15983798
Drug: Clonidine 0.2
RxNorm normalized name: CLONIDINE 0.2MG/24HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 0.2 mg
Trial: 9108861
Drug: Tricomponent acellular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tricomponent acellular pertussis-diphtheria-tetanus vaccine (fourth dose)
Trial: 3076140
Drug: Pinacidil 12.5
RxNorm normalized name: pinacidil 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pinacidil 12.5 mg bid with Hydrochlorothiazide 12.5 mg bid
Trial: 3076140
Drug: Pinacidil 12.5
RxNorm normalized name: pinacidil 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pinacidil 12.5 mg bid
Trial: 3076140
Drug: Pinacidil 25
RxNorm normalized name: pinacidil 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pinacidil 25 mg bid
Trial: 3076140
Drug: Pinacidil 37.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pinacidil 37.5 mg bid
Trial: 3076140
Drug: Pinacidil (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pinacidil (low doses 12.5-25 mg bid)
Trial: 31229307
Drug: Haloperidol (antipsychotic)
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Haloperidol (antipsychotic)
Trial: 23669822
Drug: Oral treprostinil
RxNorm normalized name: Treprostinil
DrugBank: Treprostinil (DB00374)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral treprostinil (3.1 ± 1.9 mg bid)
Trial: 19439878
Drug: IL bleomycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL bleomycin (0.1% solution with concurrent anesthesia)
Trial: 18042591
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) for induction therapy with corticosteroids for 24 weeks
Trial: 18042591
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) for maintenance therapy with corticosteroids
Trial: 18042591
Drug: Cyclophosphamide for
RxNorm normalized name: Cyclophosphamide for Injection
DrugBank: Cyclophosphamide (DB00531)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Cyclophosphamide for induction therapy with corticosteroids for 24 weeks
Trial: 18042591
Drug: Azathioprine for
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azathioprine for maintenance therapy with corticosteroids
Trial: 15088305
Drug: Cetylated fatty
RxNorm normalized name: Cetyl Alcohol
DrugBank: Cetyl alcohol (DB09494)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cetylated fatty acid (CFA) topical cream
Trial: 7943076
Drug: Intravaginal prostaglandin
RxNorm normalized name: Intravaginal contraceptives
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravaginal prostaglandin E2 (2.5 mg)
Trial: 7943076
Drug: Intracervical prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracervical prostaglandin E2 (0.5 mg)
Trial: 1387073
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with insulin and sulfonylurea
Trial: 20684786
Drug: Structured practice
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured practice nurse reviews with a specially prepared education booklet and comprehensive baseline assessment, followed by regular 3 monthly reviews over 2 years.
Trial: 10893895
Drug: Megadose heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Megadose heparin bolus (300 IU/kg body weight)
Trial: 8671129
Drug: Eradication therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eradication therapy for Helicobacter pylori
Trial: 8355105
Drug: 16 mg
RxNorm normalized name: escin 16 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 mg methylprednisolone orally the evening before surgery, combined with 20 mg methylprednisolone intravenously immediately preoperatively
Trial: 8355105
Drug: 16 mg
RxNorm normalized name: escin 16 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 mg methylprednisolone orally and 20 mg intravenously
Trial: 3125098
Drug: Control (GH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (GH therapy)
Trial: 24096862
Drug: Sequential fitting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential fitting of bilateral hearing aids
Trial: 23257685
Drug: mepolizumab (anti-IL-5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mepolizumab (anti-IL-5 monoclonal antibody)
Trial: 18561877
Drug: Tegaserod 6
RxNorm normalized name: tegaserod 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tegaserod 6 mg bid
Trial: 1334445
Drug: 2% nedocromil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% nedocromil sodium eye drops (twice daily)
Trial: 1334445
Drug: 2% sodium
RxNorm normalized name: Dextrose 5% and 0.2% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% sodium cromoglycate eye drops (four times daily)
Trial: 3881088
Drug: Glucocorticosteroid formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucocorticosteroid formulations
Trial: 25857847
Drug: i.v. parecoxib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. parecoxib sodium 40 mg
Trial: 25857847
Drug: i.v. placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. placebo (saline) 2 mL
Trial: 20592006
Drug: ATM therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATM therapy (N=47)
Trial: 7562765
Drug: Spa therapy
RxNorm normalized name: Broda Acne Spa
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spa therapy + routine drug therapy
Trial: 7438972
Drug: Oral fenoterol
RxNorm normalized name: fenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fenoterol 2.5 mg
Trial: 7438972
Drug: Oral fenoterol
RxNorm normalized name: fenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fenoterol 5 mg
Trial: 7438972
Drug: Oral fenoterol
RxNorm normalized name: fenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fenoterol 7.5 mg
Trial: 31772506
Drug: High day
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High day 1 dsDNA levels (>median; 366 ng/ml)
Trial: 27852999
Drug: Bacillus Calmette-Guerin
RxNorm normalized name: BACILLUS CALMETTE-GUERIN VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacillus Calmette-Guerin vaccine
Trial: 26087078
Drug: Disease agency
RxNorm normalized name: LYME DISEASE VACCINE
DrugBank: Lyme disease vaccine (recombinant OspA) (DB00045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disease agency language assigned to humans (e.g., 'I developed cancer')